Trial Profile
A Randomised, Placebo Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Gut Hormone Analogue G3215 in Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Dec 2020
Price :
$35
*
At a glance
- Drugs G 3215 (Primary)
- Indications Obesity
- Focus Adverse reactions
- 21 Feb 2019 Status changed from recruiting to completed.
- 05 Dec 2017 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Dec 2015).
- 03 Mar 2016 New trial record